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Thrombus that involves the popliteal, femoral, or
iliac veins is known to pose a significant risk for pul-
monary emboli and cause local destruction of venous
valves and wall structure, which leads to the post-
thrombotic (postphlebitic) syndrome. Therefore few
would disagree that proximal deep venous thrombo-
sis (DVT) in the leg should be treated with anticoag-
ulants for at least 3 to 6 months.1,2
The clinical implications of thrombi isolated to
the calf veins is less clear, and its treatment remains
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Purpose: Although the fact is well accepted that deep venous thrombosis (DVT) of the
iliac, femoral, and popliteal veins can lead to the post-thrombotic (postphlebitic) syn-
drome, the significance of isolated calf DVT on the development of late venous sequelae
and physiologic calf dysfunction is unknown. The purpose of this study was to review
the outcome of 58 limbs with isolated calf DVT and report the clinical, physiologic, and
imaging results up to 6 years after the onset of DVT.
Methods: The study consisted of 58 limbs of 54 patients in whom isolated calf vein DVT
was diagnosed between 1990 and 1995. Proximal propagation of clot, lysis of thrombi,
and development of symptomatic pulmonary emboli were examined. Of the patients, 28
received anticoagulation therapy, and 26 did not, but they had follow-up with serial
duplex scans. At late follow-up 1 to 6 years later (median, 3 years), 23 patients were
examined for the post-thrombotic syndrome, and all 23 underwent clinical examination,
color-flow duplex scanning, and air plethysmography.
Results: Proximal propagation of DVT from the calf veins into the popliteal or thigh
veins occurred in 2 of 49 cases (4%) within 2 weeks of diagnosis. No patient had clini-
cally overt pulmonary emboli develop regardless of whether anticoagulation therapy was
received or not. The most common site for calf DVT was the peroneal vein (71%).
Complete lysis of calf thrombi was found in 88% of the cases by 3 months. At 3 years,
95% of the patients were either asymptomatic or mildly symptomatic, and 5% had dis-
coloration of the limb. No ulcers occurred. By air plethysmography, physiologic abnor-
malities were found in 27% of the cases, which was not significantly different from nor-
mal controls. Valvular reflux by duplex scanning of the calf vein segment with DVT was
found in 2 of 23 cases (9%). However, reflux in at least one venous segment not involved
with DVT was found in 7 of 23 cases (30%), which was higher than, but not statistical-
ly different from, normal controls, with reflux occurring in 5 of 26 cases (19%).
Conclusions: Isolated calf vein DVT leads to few early complications (ie, clot propaga-
tion, pulmonary emboli) and few adverse sequelae at 3 years. The peroneal vein is most
commonly involved and should be a part of the routine screening for DVT. Lysis of clot
usually occurs by 3 months. Although valvular reflux rarely is found in the affected calf
vein at 3 years, reflux may be found in adjacent uninvolved veins in approximately 30%
of the cases. The question of whether this will lead to future sequelae, such as ulcera-
tion, will require longer follow-up.  (J Vasc Surg 1998;28:67-74.)
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METHODS
From 1990 to 1995, 58 limbs of 54 patients
were identified, by means of color-flow duplex scan-
ning, as having isolated calf vein clot. The scanning
was performed in the vascular laboratory with an
ATL Ultramark 9 scanner (Bothell, Wash), and
examinations were performed by one of two experi-
enced registered vascular technologists. The diagno-
sis of calf vein DVT was made on the basis of the
finding of all four criteria: (1) noncompressibility of
the vein, (2) dilation of the vein, (3) lack of a
Doppler signal, and (4) lack of visible flow. Calf vein
DVT was defined as any clot involving the deep veins
of the calf that did not extend into the popliteal vein.
Calf veins examined included the soleal, peroneal,
gastrocnemius, posterior tibial, and anterior tibial.
Gastrocnemius and soleal veins were grouped
together and referred to as gastrocnemius veins.
The accuracy of duplex scanning in the detection
of calf vein DVT was examined previously by our
vascular laboratory by the comparison of duplex
results with ascending venograms. This comparison
showed a sensitivity rate of 100%, a specificity rate of
97%, and an accuracy rate of 97%. The incidence of
an inadequate examination of calf veins because of
patient body habitus or other technical limitations is
5% or less at our institution.
The study consisted of two parts: an early phase
with retrospective review of calf DVT and a late
phase with prospective acquisition of data. The early
phase consisted of follow-up for up to 6 months to
examine early complications, such as clot propaga-
tion or the development of PE. The late phase of the
study was performed in a prospective method with
phone calls being made to all patients for whom calf
DVT had been diagnosed. All 23 patients who
returned for follow-up underwent the same proto-
col: clinical examination, color-flow duplex scan-
ning, and air plethysmography (APG; ACI Medical,
Sun Valley, Calif).
The 26 patients in the control group for the
duplex-scan data and the 10 patients in the control
group for the APG data were sex-matched and
asymptomatic. The patients in the control group
were an average of 10 years younger than the
patients in the study group. 
APG was performed, and normal and abnormal
values were used as reported by Christopoulos et
al.14-16 Valvular reflux of the calf veins was studied
by means of color-flow duplex scanning. We
acknowledge that the method of examining calf
veins is controversial. Therefore to avoid underes-
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debatable. The importance of calf vein clot propa-
gating proximally, serving as a source of pulmonary
emboli (PE), and causing the post-thrombotic syn-
drome has been the focus of recent studies. Isolated
calf DVT has been estimated to be found in 5% to
33%3,4 of all DVT cases detected by means of
duplex scanning. Some surgeons have reported sub-
stantial risk for propagation of up to 28%, which
included extension into adjacent crural veins.5
However, when proximal propagation into popliteal
or femoral veins is calculated, the incidence rate
drops to 11%. Others have reported a lower rate of
proximal propagation when patients have been fol-
lowed up with serial duplex scanning. Solis et al.6
observed an 8% rate of proximal propagation in
patients with calf DVT who were not treated with
anticoagulants.
The association of calf vein DVT and PE is also
controversial. Most studies that have examined
patients first seen with PE in whom calf DVT was
subsequently discovered report an association
between calf clot and PE, some as high as 33%.7 The
question remains whether a larger, more proximal
clot in the femoral or popliteal segment could have
embolized before the discovery of the calf clot.
Prospective studies that have followed up patients
with documented calf DVT and then examined their
clinical course have reported few cases of clinically
overt PE.6,8,9
The rate of development of the post-thrombotic
syndrome after calf DVT is reported to be 3% to
37%.10,11 In these reports—which include one series
with a follow-up that extends to 13 years10—no
ulcers have been reported. Yet, some surgeons
believe that calf DVT poses a significant risk for
severe sequelae, and they report abnormal physio-
logic test findings in 19% of such cases.12
During the Second Pacific Vascular Symposium,
held in Hawaii13 in 1996, a group of international
leaders in the field of venous disease and guests of
the symposium were polled regarding their choice in
managing calf vein DVT. Of more than 150 atten-
dees, half said they would treat calf DVT with anti-
coagulants. The other half preferred follow-up of
calf vein clot with serial duplex scans, and they treat
only those patients whose disease propagates into
the popliteal or higher levels.
The controversy over the management of calf
DVT prompted us to present our series of patients,
who were followed up for 6 years, and to report the
incidence of clot propagation, symptomatic PE, clot
lysis, and the development of valvular reflux.
timating the number of segments with valve
incompetence, we examined at the level of the knee
and below the knee with three positions: sitting,
standing, and 15-degree reversed Trendelenburg’s.
We also used three methods of inducing reflux:
Valsalva’s maneuver, manual compression, and
pneumatic cuff deflation. The thigh veins—com-
mon femoral, superficial femoral, profunda
femoris, and greater saphenous above the knee—
were examined by Valsalva’s maneuver in the 15-
degree reversed Trendelenburg’s position. We
chose to be widely inclusive in our definition of
reflux. Therefore we defined reflux as any venous
segment with retrograde flow that lasts more than
0.5 seconds by any test with any methods to elicit
reflux or any position.17
Fischer’s exact test was used to compare statisti-
cally the study group with normal controls.
RESULTS
Isolated calf vein DVT was identified in 58
limbs of 54 patients from 1990 to 1995. Of these
patients, 31 (57%) were women and 23 (43%)
were men; the median age was 64 years (range, 27
to 90 years). Risk factors for DVT are listed in
Table I. The group consisted primarily of patients
with symptomatic calf DVT. Eighty-nine percent
of the cases were first seen with limb swelling,
pain, or both. The remaining 6 of 54 cases (11%)
were asymptomatic, and detection occurred
because the patients had pulmonary symptoms
with proven PE and were subsequently discovered
to have calf DVT. 
Twenty-eight patients received anticoagula-
tion therapy, and 26 did not. Although nearly half
the group did not receive anticoagulation therapy,
no cases of symptomatic pulmonary emboli
occurred during the first 6 months of the surveil-
lance period.
Location of calf thrombi. The locations of calf
vein clot are shown in Table II. The most common
venous segment involved with calf DVT was the pe-
roneal vein, which was involved with clot in 44 of 58
limbs (76%). The left leg was more commonly
involved (67%) than the right. Bilateral DVT was
detected in 5 of 58 limbs (9%).
Propagation of thrombi. Forty-nine patients
had 2 to 6 follow-up duplex scans, with an average
of 3 studies during the first 4 weeks after DVT
developed. Of these 49 limbs, 2 (4%) had develop-
ment of proximal propagation of their initial throm-
bi. Neither patient received anticoagulation therapy.
If the percent propagation is recalculated only for
those who did not receive anticoagulation therapy,
the incidence rate of propagation is 8% (2 of 26). In
the first case of propagation, thrombus originated in
the posterior tibial vein and propagated into the
popliteal and adjacent peroneal vein on the second
day of surveillance. The patient’s risk factors were
recent air travel, estrogen use, and obesity. The sec-
ond case of extension occurred in a patient with a
peroneal-posterior tibial DVT, which extended at 2
weeks into the popliteal and superficial femoral vein.
Her risk factors included prior history of DVT and
recent orthopedic surgery. 
Pulmonary symptoms. Eight of the 54 isolated
calf DVT cases (15%) were patients who were first
seen with pulmonary symptoms and who were
found to have calf vein DVT upon scanning. All 8
patients with pulmonary symptoms and calf vein
DVT had abnormal-appearing ventilation/perfusion
scans that were highly suggestive of PE. Of the 8
patients with positive ventilation/perfusion scans
who were first seen with pulmonary symptoms, 6
had no symptoms of DVT in their legs. Asymp-
tomatic calf DVT was diagnosed as a result of the
search for a source of emboli. The question remains
whether these patients had more proximal and
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Table I. Risk factors for deep venous thrombosis
(DVT; n = 58)
Risk factor No. of cases (%)
Orthopedic surgery 18 (31)
Other major surgery 10 (17)
Air travel 12 (21)
Prior DVT 12 (21)
Prolonged immobility 6 (10)
Malignancy 5 (9)
Estrogen 2 (3)
Prior pulmonary emboli 1 (2)
Inpatient status at time of DVT 8 (14)
Table II. Location of calf vein DVT (n = 58)
Location of DVT No. of cases (%)
Peroneal vein (total) 44 (76)
Peroneal vein alone 27 (47)
Peroneal & posterior tibial veins 14 (24)
Peroneal & gastrocnemius veins 2 (3.4)
Peroneal & greater saphenous 1 (1.7)
Posterior tibial vein (total) 21 (36)
Posterior tibial vein alone 5 (9)
Posterior tibial & greater saphenous 2 (3.4)
Gastrocnemius vein alone 7 (12)
Anterior tibial vein 0 (0)
extensive thrombi that had dislodged into the lung
before scanning their calf veins.
Lysis of thrombi. Serial follow-up scanning
allowed the examination of clot lysis. The number of
limbs with complete lysis of thrombi of the involved
calf vein over time are shown in Fig. 1.
Late clinical outcome. Twenty-three patients
had late median follow-up of 3 years (range, 1 to 6
years). Of the 23 patients, 10 (43%) were totally
asymptomatic. The remaining 13 (57%) had either
swelling alone (6 cases), pain alone (4 cases), or pain
and swelling combined (3 cases). Only 1 patient
(5%) had hyperpigmentation, swelling, and varicose
veins. No ulcers were found. Clinical, etiologic,
anatomic, and physiologic classifications of each
patient, as defined by a recent consensus state-
ment,18 are shown in Table III.
The single patient with hyperpigmentation,
swelling, and varicose veins was first seen with a pe-
roneal and posterior tibial DVT. By 2 months, the
clot had lysed and reflux had developed in the pos-
terior tibial vein. By 4 years, the patient had varicose
veins, discoloration, and some swelling of the affect-
ed limb. Popliteal, posterior tibial, and perforator
reflux was identified by means of duplex scan.
Of the 9 patients with complaints of swelling, 5
did not have any objective measurement or clinical
findings of edema and they were found to have equal
circumference measurements in both legs (ankle and
calf). An interesting subgroup with reported pain
was identified in which 7 of the 7 patients had com-
plaints of knee, ankle, or hip-joint pain, similar to
symptoms they had before their orthopedic proce-
dure and calf DVT. We found no patient with classic
symptoms of venous hypertension, such as heaviness
or aching pain relieved by leg elevation. 
Late development of reflux. Valvular reflux of
at least 1 venous segment was found in 9 of 23
cases (39%). When the specific calf vein involved
with DVT was examined, reflux occurred at 3 years
in 2 of 23 cases (9%). Reflux was found in a seg-
ment not involved with DVT, such as the popliteal,
gastrocnemius, perforator, or greater saphenous
veins, in 7 of 23 cases (30%). When compared with
normal controls, the 39% reflux rate found in the
calf DVT group was higher than the reflux rate in
the control group (5 of 26 cases, 19%), but statis-
tical significance was not reached (P > 0.05). Table
IV lists the association between original calf DVT
and valvular reflux by venous segments. 
Late calf-muscle pump function. The physio-
logic state of the calf measured with APG was com-
pletely normal in 17 of 23 cases (74%). At least 1 of
3 parameters tested was found to be abnormal in
26% of the cases. In 2 cases, abnormal calf-muscle
pump was identified. Physiologic obstruction was
found in 1 patient, who was the only one with
hyperpigmentation. However, the single patient
with physiologic obstruction did not show any
anatomic obstruction of the venous system by
duplex scanning. When compared with 10 control
studies, at least 1 abnormal value was found in 30%
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Fig. 1. Percentage of limbs with total lysis of calf vein clot studied up to 1 year.
of the control groups, and statistical significance
from the study group could not be demonstrated. 
Recurrence of DVT. Recurrence of DVT
occurred in 5 of 58 limbs (9%). In 4 of 5 cases, recur-
rence was found in the leg opposite the calf DVT.
Three recurrences were seen 3 to 4 years after the
original calf clot, and the remaining 2 occurred 1 to 4
months after the original clot. 
DISCUSSION
Isolated calf DVT leads to few early complica-
tions and few late sequelae at 3 years of follow-up.
We found that the incidence rate of clot propagation
into the popliteal or higher level is approximately
4%, or as high as 8% if no anticoagulation therapy is
given, which is similar to what was reported by Solis
et al.6 Pulmonary symptoms suggestive of PE did
not occur in this group of patients who were
observed for clinical signs and symptoms up to 6
months after the calf DVT. In contrast, those
patients first seen with pulmonary symptoms of PE
and then found to have calf DVT showed high prob-
ability findings (100%) by ventilation perfusion stud-
ies, which is similar to the findings reported by
Passman et al.20 Again, the question remains
whether a more proximal clot in the thigh had dis-
lodged into the lung before the calf was scanned for
DVT and the remainder is the residual calf clot. 
The most common site for calf DVT was the
peroneal vein. Like Mattos et al.,4 we found that
clot rarely, if ever, involves the anterior tibial vein
in an isolated pattern. We had no cases of anterior
tibial vein clot in this series. In contrast, oth-
ers3,21,22 have thought the most common site to be
the posterior tibial vein. In our series, posterior tib-
ial clot alone was less common; it occurred in up to
a third of cases.
Significant post-thrombotic sequelae at 3 years
was rare. Only 1 of 23 patients had hyperpigmenta-
tion and varicose veins develop. At last follow-up,
no cases of ulceration had occurred. However,
about half the group did complain of either swelling
or pain. Although 39% had subjective complaints of
swelling, objective signs of swelling by leg inspec-
tion and circumferential measurements could be
found only in 17% of cases, which suggests that
swelling was mild in most cases. Limb pain was a
frequent complaint found in a third of the entire
group. However, when carefully questioned, all 7
patients had complaints related to their original
orthopedic surgery, disease-producing knee, or hip
pain. Degenerative joint disease was a common
problem with these patients. No cases of typical
venous insufficiency pain, such as aching calf dis-
comfort with prolonged standing or bursting-type
pain, were described.
The finding of few abnormalities by physiologic
studies correlated with the clinical findings of few
late sequelae. Calf-muscle pump dysfunction was
found only in 2 cases. Physiologic obstruction was
almost nonexistent because most clots lysed within
3 months.
The development of late reflux in the calf was
interesting. Despite calf vein clot localized to the
infrapopliteal veins, we found a number of patients
with reflux in the isolated popliteal segment without
reflux in the affected calf veins. The cause is unclear.
The question of whether popliteal vein reflux pre-
ceded calf vein DVT and possibly predisposed the
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Table III. Clinical, etiologic, anatomic, and physi-
ologic classification of patients (n = 23) with medi-
an follow-up at 3 years
Clinical, etiologic, anatomic, 
and physiologic classification No. of cases
Coa, Es, Ao, P none 7
Cos, Es, Ao, P none 4
C3s, Es, Ao, P none 2
Cos, Es, Ad, Pr14,15 1
Coa, Es, Ad, Pr14 1
C2a, Es, Ap, Pr18 1
Coa, Es, Ad, Pr14 1
Cos, Es, As,d Pr3,13,14,16 1
Cos, Es, Ad, Pr14 1
C2s, Es, Ao, P none 1
C2,3,4s, Es, Ad,p, Pr14,15,18,0 1
Cos, Es, As, Pr3 1
C3s, Es, Ad,p, Pr14,18 1
C, Clinical; E, etiology; A, anatomy; P, physiology.18
Table IV. Correlation between original location of
deep venous thrombosis (DVT) and development
of reflux
Original location of calf DVT Location of reflux
Peroneal and posterior Popliteal (3 cases)
Tibial DVT (5 cases) Popliteal and posterior tibial,
perforator (1 case)
Popliteal and peroneal 
(1 case)
Peroneal DVT (1 case) Greater saphenous vein, 
below knee
Gastrocnemius DVT (1 case) Perforator
Posterior tibial DVT (2 cases) Superficial femoral, popliteal,
gastrocnemius, greater 
saphenous (1 case)
Popliteal, perforator (1 case)
patient to DVT or whether popliteal reflux was the
result of calf vein clot remains unknown. Despite
finding reflux in 9 of 23 patients, symptoms relating
to reflux were few. 
On the basis of our previous work on the diag-
nosis of venous reflux by duplex scanning,17 we
anticipated difficulty in showing tibial vein reflux.
Therefore we chose to study all patients in 3 differ-
ent positions: sitting, standing, and reversed
Trendelenburg’s at 15 degrees. We also used 3 dif-
ferent methods to induce reflux: Valsalva’s maneu-
ver, pneumatic cuff, and manual compression. This
intense method was used to minimize any possibili-
ty of missing detectable reflux. Despite this thor-
ough investigation, in 91% of cases reflux was not
found in the involved calf vein, which in all cases was
recanalized by 3 years.
The patients in the control group used to inter-
pret duplex scan and APG findings were younger
than the patients in the study group by a mean of
10 years. Although not ideal, the finding of a sub-
stantial number of abnormal studies in the normal
group suggests that even an older group of normal
controls would produce an equivalent, or even
higher, number of abnormal test results and may
not alter the conclusions.
If one chooses to observe patients with close
duplex scan surveillance rather than treatment with
anticoagulants, the question is the interval and the
frequency of examinations. The 2 cases of clot prop-
agation in this series occurred during the first 2
weeks of observation—2 days and 14 days after the
initial diagnosis of DVT. On the basis of these find-
ings, we recommend that serial duplex scans be per-
formed during the first week (at days 3 and 7) and
at the end of 2 weeks. Beyond 2 weeks, the likeli-
hood of clot propagation is low. A scan at 4 weeks
can be done to check for clot lysis and reflux, but
this is optional.
The argument in favor of treating calf vein clot
with anticoagulation therapy is the avoidance of clot
propagation, possibly fatal PE, and post-thrombotic
sequelae. The argument against treating all cases of
calf vein DVT relates to the risk of anticoagulation
therapy and the cost of treatment, including materi-
als, medical resources, and the patient’s time away
from work. When comparing the cost of outpatient
surveillance versus inpatient hospitalization with
heparin anticoagulation for 5 days, blood tests, and
3 months of warfarin treatment, the difference is
enormously in favor of outpatient management with
either duplex surveillance or low-molecular-weight
heparin treatment.
CONCLUSIONS
Thrombi that are isolated to the calf veins
appear to have a low risk for PE, proximal exten-
sion, and development of the post-thrombotic
syndrome.
The most common site for isolated DVT in the
calf is the peroneal vein. The data suggest that the
peroneal vein (paired) must be part of the general
screening examination by duplex scanning when
evaluating for DVT.
If clot propagation occurs, it usually will do so
within 2 weeks of the initial diagnosis of DVT.
Therefore if surveillance without anticoagulation
therapy is selected, duplex scanning and close fol-
low-up should be carried out for a minimum of 2
weeks after the initial diagnosis.
After 3 months, most clot will have lysed, and
repeat duplex scanning beyond 3 months will have
little effect on management. At 3 years, approxi-
mately half of all cases will have some complaint of
swelling or pain, but most of the swelling is subjec-
tive, and pain may be caused by the orthopedic-
related illness for which the patient had surgery, such
as degenerative joint disease. Typical venous hyper-
tension–type pain, such as an aching discomfort or
feeling of heaviness that improves with leg elevation,
is rare. Only 5% of cases will have hyperpigmentation
at 3 years, and ulceration would be rare. Reflux will
be found in the original calf vein involved with clot
in 9% of cases, and 30% of cases will have reflux in
uninvolved segments. The question of whether
reflux found in a third of cases is significant or if it
will lead eventually to ulceration remains to be stud-
ied with longer follow-up. 
We thank Anna M. Judilla and Michelle W. Tang for
their valuable contribution in completing the data collec-
tion for this project.
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ond question asks if the authors might speculate why this
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Now, at 3 years, only 23 patients reported for follow-
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over Route 50. So, one must presume that they were doing
well or have sought out other consulations. I tend to doubt
this given the outstanding nature of the Straub group.
Finally, they raise the intriguing question about how one
should treat infracrural deep venous thrombosis. I would like
to ask how many people treat infracural deep venous throm-
bosis with anticoagulation? How many with watchful wait-
ing? The majority. I ask the same question to the authors,
and I ask their opinion about this pressing issue.
It was a privilege and a pleasure to review this thought-
ful report from the Straub Clinic. Thank you.
Dr. Elna M. Masuda. Thank you for your insightful
comments. There have been many retrospective reports
published that examine the association between pul-
monary emboli and calf vein deep venous thrombosis.
Previous studies, including one from our institution, sug-
gested that calf deep venous thrombosis and pulmonary
emboli occur simultaneously in up to one third of patients.
Although patients were found to have simultaneous pul-
monary emboli and deep venous thrombosis, the question
is whether the clot in the lung originated from the clot in
the calf, or whether it came from a source higher in the
Dr. Ralph DePalma (Reno, Nev.). It is a privilege to
discuss this study that provides information on the out-
come of 58 limbs with infracrural deep venous thrombosis
in 54 patients. This is a unique natural history study that
looks at end points of proximal clot propagation, lysis, and
possible pulmonary emboli in the short term, and in the
long term, we learn about late sequelae. These interesting-
ly proved to be physiologic reflux abnormalities in 27% to
32% as judged by air plethysmography and duplex scan.
The authors used a control group to compare these
abnormalities discovered in their index patients, and we
will ask about the composition of that control group. No
class 5 or 6 abnormalities occurred in the long term.
There was good news and bad news in this study. The
good and surprising news was that only 4% had proximal
propagation of clot irrespective of treatment. There were
no pulmonary emboli. Now, this compares with the dire
results of up to 33% propagation in previous studies that
underscore the serious nature of calf vein thrombosis,
including a report by Dr. Kistner, in 1976. This raises the
question of why the divergence exists between this and
other series. This current data certainly support watchful
waiting for calf deep venous thrombosis.
The bad news is that although clot lysis has been clear-
ly shown by careful serial duplex scanning, there are resid-
ual reflux changes—not necessarily in the same vein—as
initially affected by the deep venous thrombosis. My sec-
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DISCUSSION
thigh. The answer is difficult to achieve by retrospective
reviews. We therefore tried to achieve a better under-
standing of the relationship by this prospective series in
which we found that calf vein deep venous thrombosis
rarely leads to symptomatic pulmonary emboli. 
Interestingly, at 3 years, reflux was present in areas of
venous segments not involved with deep venous throm-
bosis in one third of cases. To explain this finding, we
speculate that reflux may have been present in these seg-
ments before the deep venous thrombosis and that reflux
is not a direct result of the calf vein thrombi. It may be
that preexisting popliteal reflux led to venous stasis in the
calf and predisposed the patient to calf vein clot. An accu-
rate explanation for this observation, however, remains to
be proven by further studies.
Regarding the follow-up, the number of these patients
who were seen at 3 years was limited because it was diffi-
cult to get them to return for objective testing. Most
patients reached by phone refused to come for objective
testing because they were asymptomatic. They did not see
any benefit in two tests and an examination for a problem
they had 3 years ago that left them without symptoms.
Although compelling, these phone interview responses
were omitted from the study because of their subjectivity.
Of the 23 who did return for testing, many came for
follow-up because they had joint pain related to an ortho-
pedic problem or surgery that preceeded the calf deep
venous thrombosis. These patients wanted further testing
of the limb. Although a substantial number reported joint-
related pain, only 8% were found to have reflux in the pre-
viously thrombosed calf vein.
Finally, the last question regarding the best method of
managing patients with calf vein deep venous thrombosis
remains unanswered. However, the results of our study
support no anticoagulation and close surveillance by
duplex scanning. The low incidence rate of clot propaga-
tion, symptomatic pulmonary emboli, and postthrombot-
ic syndrome supports the concept that surveilllance of calf
deep venous thrombosis is feasible. Yet, scanning must be
performed by a vascular lab that has a high accuracy rate
for scanning below the popliteal vein.
Dr. Robert L. Kistner. I will address the observation
that Dr. DePalma raised of why we reported 33% of pul-
monary embolis associated with calf vein thrombi in
1976. The reason I comment is because I think that con-
clusion should be scratched from the body of reasonable
information.
That was a carefully performed study. However, it was
done in the early days of lung scanning when we called all
small defects on the lung scan, even peripheral scallops,
positive studies for pulmonary embolism. This was before
the PIOPED study.
So, the data in that report, although carefully done, in
the light of present-day interpretation of lung scan would
not be valid for the dianosis of pulmonary embolism any
longer.
Dr. Sergio Salles-Cunha (Toledo, Ohio). I would like to
emphasize the point that the reflux might have been there
before this episode of deep venous thrombosis. It was not
proven that the reflux was caused by venous thrombosis.
I have the following two questions: should we scan
routinely the anterior tibial veins, and what about muscle
vein thrombosis?
Dr. Masuda. The anterior tibial vein is scanned rou-
tinely in our vascular laboratory for anyone who under-
goes examination for deep venous thrombosis. Yet, on the
basis of our data finding no cases of anterior tibial clot
with isolated calf vein deep venous thrombosis, I do not
think we can advocate scanning the anterior tibial vein
routinely. Although it is not involved with thrombosis in
isolated calf deep venous thrombosis cases, the anterior
tibial can be involved when other deep veins are clotted,
such as the popliteal vein.
Muscular vein thrombi that involve the gastrocnemius
or soleal veins were found in about one fifth of our entire
series. Therefore, we advocate scanning them in the rou-
tine examination for deep venous thrombosis.
Dr. Gregory Moneta (Portland, Ore.). We presented
a paper with similar findings at the Joint Vascular meetings
in June. We also found that there seem to be sites of reflux
in these patients away from the site of the documented
venous thrombosis.
We also studied a group of control patients to ensure
that we were not overdiagnosing reflux in patients who
were asymptomatic. We found virtually no reflux in the
control patients. Either reflux has developed because of
problems with silent deep venous thrombosis in other
locations, or perhaps preexisting reflux places the patient
at risk for calf vein thrombosis.
Dr. Masuda. We cannot draw any conclusions regard-
ing risk factors for clot propagation from this study
because we only had 2 of 49 cases with propagation. These
were described in the paper. Other prospective studies
looking specifically at risk factors have not yet clearly iden-
tified any predictive factors for thrombi propagation.
Dr. Kenneth McIntyre (Galveston, Tex.). I enjoyed
the paper. I think that the question is whether the calf vein
thrombosis propagates into the popliteal vein or above the
knee and then enhances the risk for pulmonary emboliza-
tion or further propagation.
So, in the group in which 4% propagated, could you
identify the specific risk factors that would make you treat
them? Could you separate them from the other group that
did not propagate? Perhaps that would help us decide in
the future who to treat aggressively and who to release
without any therapy at all.
Dr. Masuda. When discussing treatment of calf vein
deep venous thrombosis, currently there are the following
three choices: surveillance with select treatment of those
who propagate; low molecular weight heparin with subcu-
taneous injections as an outpatient for 5 days and then
warfarin for 1 to 3 months; hospitalization and anticoag-
ulation with unfractionated heparin for 5 days, followed
by warfarin for 3 months.
I think that in the future the most likely two alternatives
will be duplex surveillance and selective treatment, or treat-
ment with low molecular weight heparin as an outpatient.
These alternatives would be less costly when compared with
hospitalization and treatment with unfractionated heparin,
and feasible if early and late outcome are equivalent.
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